The prototypical pain neuropeptide — an eleven-amino-acid tachykinin released by the fine nerve endings that fire first when tissue is injured. It transmits "this hurts" up the spinal cord, and then spills back out to make the injured tissue itself inflamed: the sensory nerve acting as a gland.
Chemical Class
Tachykinin peptide (11 aa)
Source
Small-diameter sensory C-fibers (dorsal root ganglia), CNS, GI enteric neurons
Synthesized in dorsal-root ganglion neurons and shipped both directions: centrally to the dorsal horn (pain transmission) and peripherally to the tissue (neurogenic inflammation).
Released by intense noxious input — capsaicin's burn empties substance P stores, which is how TRPV1 activation and pain fiber firing couple to peptide release.
Angiotensin-converting enzyme and neutral endopeptidase terminate it locally; the short half-life keeps the alarm local.
Mechanism of Action
Substance P binds the NK1 receptor (Gq/IP3): postsynaptic dorsal-horn neurons depolarize and relay pain upward; peripheral targets vasodilate, leak plasma and summon immune cells. NK1 receptors in the brainstem vomiting centers are the target of aprepitant — the anti-nausea drug designed from this pathway.
Physiological Effects
Pain transmission: slow synaptic excitation in the dorsal horn — the peptidergic component of the pain signal, alongside fast glutamate.
Neurogenic inflammation: the wheal-and-flare around an injury is partly substance P leaking from sensory endings — vasodilation, plasma extravasation, mast-cell histamine release.
Smooth muscle: contracts gut and airway smooth muscle (the tachykinin name means exactly that) and modulates GI motility.
Nausea and vomiting: NK1 receptors in the brainstem emetic circuit — aprepitant blocks chemotherapy vomiting.
Mood: elevated substance P is implicated in depression and anxiety — NK1 antagonism was an antidepressant lead.
Interactions & Feedback
Opposed by the descending endorphin/enkephalin system in the dorsal horn — the push-pull of pain gating.
Travels with CGRP: the two neuropeptides co-exist in C-fibers and jointly drive neurogenic inflammation and migraine biology.
Interacts with serotonin in the gut (motility) and in emetic circuits.
Amplified by NGF in inflamed tissue — the sprouting of substance P fibers is why chronic inflammation hurts more.
When It Goes Wrong
Chronic pain and neuropathic pain: substance P/NK1 upregulation in the dorsal horn contributes to central sensitization — pain amplification outliving the injury.
Vomiting of chemotherapy: NK1 antagonists (aprepitant) are standard antiemetic partners — the pathway's biggest clinical win.
Migraine and cluster headache: trigeminal substance P release participates in the neurovascular headache cascade (with CGRP).
Irritable bowel and airway hyperreactivity: enteric and airway tachykinin excess — smooth-muscle and secretion effects made chronic.